Epigenetic drug discovery and tools
 

Management and Board

Management

 

    Barrie Ward   Executive Chairman
    Will West   Chief Executive
    Tim Fell  Chief Operating Officer
    David Knowles  Chief Scientific Officer
    Nessa Carey  Scientific Director
    Neil Pegg Director of Discovery Research
    Jonathan Best Programme Manager
    Dev Crease  Patent Counsel
    Richard Brooks Finance Director
    Thea Stanway  Finance Officer

  

Board

 

    Barrie Ward  Executive Chairman
    Will West  Executive Director
    Tim Fell Executive Director
    David Knowles Executive Director
    Gerald Chan Non-Executive Director
    Sue Foden Non-Executive Director
    Dan Roach Non-Executive Director
    David Secher Non-Executive Director
    Azim Surani Board Observer
 

  

Nessa Carey (Scientific Director)

Nessa CareyNessa obtained a degree in Immunology from North East Surrey College of Technology and her PhD in Virology from the University of Edinburgh.  Following a post-doctoral position in human neurogenetics at Charing Cross and Westminster Medical School she became a Lecturer and then Senior Lecturer in Molecular Biology at Imperial College School of Medicine.  

 

In 2001 Nessa joined Vernalis in the days when it was a specialist neuroscience company, initially as Director of Molecular Biology and ultimately as Head of Molecular Biology and Pharmacology.  In 2004 she moved into oncology and epigenetics drug discovery, becoming Head of Biology for TopoTarget before joining CellCentric in June 2006.